NeoGenomics, Inc. Increase (Decrease) in Contract with Customer, Asset
NeoGenomics, Inc. (NEO) reported Increase (Decrease) in Contract with Customer, Asset of $200.00 thousand for the 9-month period ending 2021-09-30, per its 10-Q filed 2021-11-04.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInContractWithCustomerAsset · last filed 2021-11-04
- NeoGenomics, Inc. increase (decrease) in contract with customer, asset for the quarter ending 2021-09-30 was $0.00, a 100.00% decline year-over-year.
- NeoGenomics, Inc. increase (decrease) in contract with customer, asset for the quarter ending 2021-06-30 was -$200.00K, a 300.00% decline year-over-year.
- NeoGenomics, Inc. increase (decrease) in contract with customer, asset for the quarter ending 2021-03-31 was $400.00K, a 100.00% increase year-over-year.
- NeoGenomics, Inc. increase (decrease) in contract with customer, asset for the quarter ending 2020-09-30 was $400.00K, a 100.00% increase year-over-year.
| Period end | Increase (Decrease) in Contract with Customer, Asset 3 month | Increase (Decrease) in Contract with Customer, Asset 6 month | Increase (Decrease) in Contract with Customer, Asset 9 month |
|---|---|---|---|
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | -$200.00K derived: sum of 2 quarters · filed 2021-11-04 | $200.00K 10-Q · filed 2021-11-04 |
| 2021-06-30 | -$200.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $200.00K 10-Q · filed 2021-08-09 | |
| 2021-03-31 | $400.00K 10-Q · filed 2021-05-06 | ||
| 2020-09-30 | $400.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | $500.00K derived: sum of 2 quarters · filed 2020-10-29 | $700.00K 10-Q · filed 2020-10-29 |
| 2020-06-30 | $100.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-31 | $300.00K 10-Q · filed 2020-07-31 | |
| 2020-03-31 | $200.00K 10-Q · filed 2020-04-29 | ||
| 2019-09-30 | $200.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13 | $200.00K derived: sum of 2 quarters · filed 2019-11-13 | $500.00K 10-Q · filed 2019-11-13 |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $300.00K 10-Q · filed 2019-08-07 | |
| 2019-03-31 | $300.00K 10-Q · filed 2019-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 20/20 Biolabs, Inc. (AIDX) | United States | $0.005B |